Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Go back to Haemonetics 4th Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website

Haemonetics (HAE) Tops Q4 EPS by 7c

May 11, 2023 6:05 AM EDT

Haemonetics (NYSE: HAE) reported Q4 EPS of $0.77, $0.07 better than the analyst estimate of $0.70. Revenue for the quarter came in at $304 million versus the consensus estimate of $290.79 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

... More